Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer

NCT01134497 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped New information on IMP affected the cost/benefit ratio

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Placebo
DRUG: ZD4054

Sponsor

Cardiff University